Scarica l'app Stockscreener
1.40
12.50%
-0.20
Precedente Chiudi:
$1.60
Aprire:
$1.6
Volume 24 ore:
73,731
Relative Volume:
0.60
Capitalizzazione di mercato:
$39.66M
Reddito:
$48.20M
Utile/perdita netta:
$-35.05M
Rapporto P/E:
-0.8933
EPS:
-1.5673
Flusso di cassa netto:
$-13.02M
1 W Prestazione:
-25.93%
1M Prestazione:
-9.68%
6M Prestazione:
-20.00%
1 anno Prestazione:
-36.94%
Intervallo 1D:
$1.385
$1.6169
Intervallo di 1 settimana:
$1.385
$1.8599
Portata 52W:
$1.06
$4.35
Celularity Inc Stock (CELU) Company Profile
Nome
Celularity Inc
Settore
Industria
Telefono
(908) 768-2170
Indirizzo
170 PARK AVE, FLORHAM PARK
Confronta CELU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.40 | 45.33M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-30 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-06 | Downgrade | Truist | Buy → Hold |
| 2022-01-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Celularity Inc Borsa (CELU) Ultime notizie
There Is A Reason Celularity Inc.'s (NASDAQ:CELU) Price Is Undemanding - simplywall.st
Market Outlook: Why Celularity Inc Equity Warrant stock is considered a top pickWeekly Trade Summary & Weekly Chart Analysis and Guides - moha.gov.vn
Celularity receives FDA warning over marketing claims - MSN
Celularity (NASDAQ:CELU) Trading 0.4% HigherShould You Buy? - MarketBeat
Celularity Shares Face Persistent Headwinds Amid Regulatory and Financial Challenges - AD HOC NEWS
Celularity Receives FDA Warning Over Marketing Claims - TipRanks
Celularity Inc Receives FDA Warning Letter - TradingView — Track All Markets
Is Celularity Inc. Equity Warrant stock attractive for ETFsTrade Volume Report & Growth Oriented Trade Recommendations - Newser
Will Celularity Inc. Equity Warrant stock benefit from commodity pricesWeekly Gains Summary & Growth Focused Stock Reports - Newser
Is Celularity Inc. Equity Warrant stock positioned for digital transformationMarket Performance Summary & Technical Confirmation Trade Alerts - Newser
Why analysts upgrade Celularity Inc. stockForecast Cut & Free Technical Pattern Based Buy Signals - Newser
Is Celularity Inc. Equity Warrant stock a safe investment in uncertain markets - Newser
Celularity (CELU) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Celularity Inc. (CELU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CELU announces CFO termination; appoints interim incharge - MSN
Celularity, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
[Form 4] Celularity Inc Insider Trading Activity - Stock Titan
Form 4: Celularity (CELU) director now holds 248,765 Class A shares - Stock Titan
Is Celularity Inc. Equity Warrant stock attractive after correctionWeekly Trading Summary & Expert Verified Movement Alerts - newser.com
Will Celularity Inc. Equity Warrant stock attract more institutional investors - newser.com
Is Celularity Inc a good long term investmentLarge Cap Stability Picks & Accelerated Capital Growth - earlytimes.in
Chart based analysis of Celularity Inc. Equity Warrant trendsQuarterly Profit Report & Safe Capital Preservation Plans - newser.com
Will Celularity Inc. Equity Warrant stock maintain momentum in 20252025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Quantitative breakdown of Celularity Inc. Equity Warrant recent moveQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Using data models to predict Celularity Inc. Equity Warrant stock movementTrade Entry Report & AI Enhanced Trading Alerts - newser.com
Can Celularity Inc. Equity Warrant stock beat market expectations this quarterMarket Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Backtesting results for Celularity Inc. trading strategiesWeekly Profit Report & Long-Term Capital Growth Ideas - newser.com
Should you wait for a breakout in Celularity Inc.Insider Selling & Technical Pattern Based Buy Signals - newser.com
What analysts say about Celularity Inc stockSector Leadership Analysis & Ride the Wave of Market-Beating Growth - earlytimes.in
What does recent volatility data suggest for Celularity Inc.Forecast Cut & High Accuracy Trade Alerts - newser.com
Is Celularity Inc. Equity Warrant stock attractive for long term wealth buildingWeekly Trend Recap & Capital Efficiency Focused Ideas - newser.com
LEVIEN VINCENT Insider Trades - Nasdaq
How to use a screener to detect Celularity Inc. Equity Warrant breakoutsJuly 2025 PostEarnings & Fast Entry Momentum Trade Alerts - newser.com
What momentum shifts mean for Celularity Inc. Equity WarrantTrade Signal Summary & Technical Pattern Based Signals - newser.com
Celularity Inc Azioni (CELU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):